Genesis MedTech Receives Approval for Launch in China for ArtiSential™

07th July, 2023

Genesis MedTech, a leading medical device company, announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release.

ArtiSential™ is a laparoscopic surgical device that mimics the movement of a surgeon's wrist and fingers, providing multiple clinical advantages that enhance surgical precision and outcomes. The device's double-joint end-effector allows for 360 degrees of freedom in movement, providing full access to narrow surgical sites. It operates on a fully mechanical structure with tactile feedback conduction, enabling the surgeon to have a realistic feel of the endoscopic operation. The device also offers a full range of customized end-effectors, making it a versatile tool that can meet various clinical requirements.

 

ArtiSential™ was developed by LivsMed, a distinguished medical device company in Korea. In 2021, Genesis MedTech and LivsMed signed an exclusive distribution agreement to introduce ArtiSential™ to the Chinese market.

ArtiSential™ made its debut in Korea in 2018, followed by its launch in the US market the following year. The product's exceptional design earned it the Red Dot Design Award. Today, ArtiSential™ is available in several countries including US, GermanyJapan, the UK, and Australia, and has received widespread acclaim from medical professionals who specialize in minimally invasive surgery.

The launch of ArtiSential™ equips surgeons in China with a state-of the-art instrument that will enhance their skills to provide even better care to their patients.

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer